Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testing
about
Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testing
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@ast
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@en
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@nl
type
label
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@ast
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@en
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@nl
prefLabel
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@ast
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@en
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@nl
P2093
P2860
P356
P1476
Statin pharmacogenomics: oppor ...... are costs with genetic testing
@en
P2093
David G Brooks
Donald Chaplin
E Robert Wassman
Elizabeth Lawler
Lori Martell
Niteesh K Choudhry
Troyen Brennan
William J Canestaro
P2860
P304
P356
10.3390/JPM2040158
P577
2012-10-17T00:00:00Z